Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning (Allergen) - Olivia & Leo Gourmet Treats brand Dark 55% Cacao Almond Bark recalled due to undeclared milk


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/olivia-leo-gourmet-treats-brand-dark-55-cacao-almond-bark-recalled-due-undeclared-0

OTTAWA, ON, Dec. 30, 2022 /CNW/ - 

Summary

Affected products

Brand

Product

Size

UPC

Codes

Olivia & Leo
Gourmet Treats

Dark 55% Cacao
Almond Bark

120 g

6 28634 07609 5

BB : 16 JL 2023

Lot : 2321

 

Issue

The affected product is being recalled from the marketplace because it may contain milk which is not declared on the label.

The recalled product has been sold nationally.

What you should do

Learn more:

Background

This recall was triggered by the company.

There have been no reported reactions associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 08:00
Interviews available with RTOERO experts, Canadian and international speakers. WHEN:         Wednesday, May 15          (7?9PM)Thursday, May 16              (8:30AM?8PM) Friday, May 17                   (8:30AM?12:15PM) WHERE:      ...

at 08:00
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased to announce the expansion of two research collaborations to align with its recently...

at 07:45
IntelGenx Technologies Corp. (the "Company" or "IntelGenx") announces that, at the annual meeting of shareholders of the Company held on May 7, 2024 (the "Annual Meeting"), shareholders voted in favour of all items of business put forth by the...

at 07:30
Carisma Therapeutics Inc.  ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced new data demonstrating preclinical proof of concept using...

at 07:30
NeuroTherapia, an early-stage clinical pharmaceutical company, announced today that it has received a grant from the Alzheimer's Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of...

at 07:30
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced today that it has...



News published on and distributed by: